Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Rating of “Hold” by Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been assigned a consensus recommendation of “Hold” from the four analysts that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $4.00.

Several equities research analysts have issued reports on the stock. Wall Street Zen cut shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th. Weiss Ratings cut shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Thursday, June 11th.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several institutional investors and hedge funds have recently added to or reduced their stakes in BIOX. Jones Financial Companies Lllp boosted its stake in Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE boosted its stake in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares during the last quarter. Virtu Financial LLC acquired a new stake in Bioceres Crop Solutions during the 3rd quarter worth $40,000. Invesco Ltd. acquired a new stake in Bioceres Crop Solutions during the 4th quarter worth $45,000. Finally, PDT Partners LLC boosted its stake in Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after purchasing an additional 10,449 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX opened at $0.41 on Wednesday. The firm has a market cap of $25.82 million, a PE ratio of -0.11 and a beta of 0.39. The firm has a fifty day moving average of $0.49 and a 200 day moving average of $0.79. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.70 and a current ratio of 0.88. Bioceres Crop Solutions has a one year low of $0.35 and a one year high of $5.00.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings results on Monday, May 11th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.11). The company had revenue of $39.40 million during the quarter, compared to analysts’ expectations of $54.50 million. Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%. As a group, research analysts predict that Bioceres Crop Solutions will post -0.16 EPS for the current fiscal year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.